AbsoluteCare Secures $135 Million Investment for Expansion

July 22, 2025
AbsoluteCare has secured $135 million in equity financing from investors including CVS Health Ventures and Kinderhook Industries to expand its value-based healthcare services.

AbsoluteCare has secured $135 million in equity financing from a group of investors, including CVS Health Ventures, Kinderhook Industries, Pacific Life, and Lexington Partners, announced in a press release. This funding aims to enhance AbsoluteCare's operations and facilitate its expansion into new markets, focusing on providing comprehensive healthcare to vulnerable and chronically complex members.

The investment will support AbsoluteCare's Beyond Medicine™ model, which integrates social determinants of health support, behavioral health care, primary and urgent care, and pharmacy services. This approach has reportedly led to a 34% reduction in emergency department visits and a 20-30% decrease in total care costs for its members.

With 25 years of experience, AbsoluteCare operates in 11 markets across the United States, offering services through comprehensive care centers located in urban communities. The company is committed to improving health outcomes by increasing interactions with primary care providers and reducing unnecessary healthcare utilization.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

09/05
EverTrue Acquires DonorSearch to Enhance Fundraising Intelligence
09/05
Anthropic Restricts AI Services to Chinese-Owned Entities
09/04
Dyna Robotics Eyes $600 Million Valuation in New Funding Round
09/04
Sierra Technologies Nears $350 Million Funding Round
09/04
Lambda Prepares for IPO with Major Investment Banks

More from: Life Sciences

09/04
Ultrasound AI Secures U.S. Patent for AI-Driven Clinical Value Determination
09/04
Hoth Therapeutics Adopts Lantern Pharma's AI Platform for Drug Development
09/04
Ketryx Secures $39M Series B to Enhance AI Compliance in Life Sciences
09/04
BioLab Holdings Invests in AI Diagnostic Tech with cureVision
09/04
Proprio Adds Rocket Lab CFO Adam Spice to Board

Subscribe to AI Funding Brief

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like